AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. - Meynier M; Baudu E; Rolhion N; Defaye M; Straube M; Daugey V; Modoux M; Wawrzyniak I; Delbac F; Villéger R; Méleine M; Borras Nogues E; et al. (Gut microbes, 2022)